发明名称 |
Soluble PD-1 variants, fusion constructs, and uses thereof |
摘要 |
The subject invention provides novel soluble PD-1 (sPD-1) proteins, nucleic acids, and fusion constructs thereof, for enhancing humoral and cell-mediated immunity of a subject. Also provided are therapeutic compositions comprising the sPD-1 proteins, nucleic acids, and fusion constructs of the subject invention. In a preferred embodiment, the therapeutic composition is formulated as a vaccine composition. Advantageously, the sPD-1 proteins, nucleic acids, and therapeutic compositions provide protective immunity against pathogenic infection including HIV infection. In addition, the subject invention can be used in the prevention and/or treatment of tumor or cancer. |
申请公布号 |
US9029315(B2) |
申请公布日期 |
2015.05.12 |
申请号 |
US201113294306 |
申请日期 |
2011.11.11 |
申请人 |
The University of Hong Kong |
发明人 |
Chen Zhiwei;Zhou Jingying |
分类号 |
A01N61/00;A61K38/00;A61K38/16;C07K14/705;A61K39/21;C07K14/005;A61K39/00 |
主分类号 |
A01N61/00 |
代理机构 |
Saliwanchik, Lloyd & Eisenschenk |
代理人 |
Saliwanchik, Lloyd & Eisenschenk |
主权项 |
1. A PD-1 DNA molecule encoding a soluble PD-1 protein comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 11, SEQ ID NO: 15, and SEQ ID NO: 25. |
地址 |
Hong Kong CN |